GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

VentriPoint Diagnostics VPT.V · CAD

Health Care · TSX Venture · 🇨🇦 Canada

Compare

0.07

-7.14%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CAD, from our data supplier.

FY2025

Revenue

C$179,928

FY2016FY2025

Net income

−C$3.2m

FY2016FY2025

Free cash flow

−C$1.6m

FY2016FY2025

Shareholders' equity

−C$4.1m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueC$179,928C$95,172C$49,183C$68,167—C$36,017C$81,023C$60,177C$38,905C$209,479
Research and developmentC$372,910C$969,243C$1.1mC$1.1mC$457,341C$272,041C$1.0mC$1.5mC$1.2mC$1.2m
Operating income−C$3.4m−C$4.8m−C$4.9m−C$4.9m−C$3.7m−C$1.9m−C$3.3m−C$3.8m−C$3.4m−C$2.1m
Net income−C$3.2m−C$4.9m−C$4.9m−C$4.9m−C$3.9m−C$1.9m−C$3.3m−C$2.1m−C$3.7m−C$2.6m
Diluted earnings per share-0.02-0.03-0.03-0.03-0.02-0.02-0.05-0.03-0.07-0.09

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsC$472,082C$658,024C$1.9mC$6.0mC$9.5mC$801,570C$314,280C$466,487C$1.7mC$672,502
Cash and short-term investments——C$1.3mC$5.2mC$9.3mC$526,026C$13,761C$66,566C$1.4mC$191,282
Total liabilitiesC$4.6mC$3.6mC$1.7mC$1.4mC$1.2mC$3.2mC$2.8mC$1.4mC$3.3mC$2.9m
DebtC$35,824C$58,779C$274,378C$459,078C$159,969C$1.4mC$1.1mC$567,184—C$597,122
Shareholders' equity−C$4.1m−C$3.0mC$189,706C$4.6mC$8.3m−C$2.3m−C$2.5m−C$973,263−C$1.6m−C$2.2m
Shares outstanding157m157m157m157m156m90m69m60m52m29m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−C$1.6m−C$3.4m−C$3.8m−C$4.1m−C$3.1m−C$1.1m−C$2.4m−C$3.0m−C$3.1m−C$2.2m
Capital spending————−C$4,257−C$3,763−C$17,098−C$27,374−C$39,047−C$13,988
Free cash flow−C$1.6m−C$3.4m−C$3.8m−C$4.1m−C$3.2m−C$1.1m−C$2.4m−C$3.1m−C$3.1m−C$2.2m

Latest quarters

By quarter end

Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024
RevenueC$4,304C$104,304—C$71,320—C$64,507C$30,665—
Operating income−C$738,605−C$645,959−C$1.2m−C$846,547−C$1.1m−C$1.2m−C$1.4m−C$1.2m
Net income−C$199,752−C$752,084−C$1.3m−C$959,780−C$1.1m−C$1.3m−C$1.4m−C$1.2m
Diluted earnings per share-0.00-0.00-0.01-0.01-0.01-0.01-0.01-0.01
Cash from operations——————−C$1.0m—
Total assetsC$472,082C$377,120C$526,611C$886,499C$658,024C$718,065C$670,518C$853,647
Cash and short-term investments———————C$375,009
DebtC$35,824C$41,974C$47,825C$53,422C$58,779C$1.1mC$929,576C$130,789
Shareholders' equity−C$4.1m−C$4.7m−C$4.1m−C$3.5m−C$3.0m−C$2.5m−C$2.1m−C$922,915

Growth per year

Compound annual rate

3 years5 years10 years
Revenue38.2%37.9%12.4%
Operating income-11.5%12.5%5.4%
Net income-13.1%11.6%7.8%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-2981.2%-4597.4%——
Net margin-2951.6%-4552.1%——

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-6.9-3.2-9.5-8.7-13.8-4.4-1.6-4.5-4.3-1.3
Price to sales122.3165.1———225.164.3155.1411.616.8

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 10-to-1 reverse split · 7 Dec 2015

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.